Treace Medical Concepts Inc (TMCI)
5.76
+0.33
(+6.08%)
USD |
NASDAQ |
Nov 05, 16:00
6.70
+0.94
(+16.32%)
After-Hours: 20:00
Treace Medical Concepts Cash from Operations (Quarterly): -13.90M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -13.90M |
| March 31, 2024 | -7.221M |
| December 31, 2023 | 0.532M |
| September 30, 2023 | -9.513M |
| June 30, 2023 | -8.335M |
| March 31, 2023 | -17.26M |
| December 31, 2022 | -5.358M |
| September 30, 2022 | -7.483M |
| June 30, 2022 | -10.57M |
| Date | Value |
|---|---|
| March 31, 2022 | -7.241M |
| December 31, 2021 | -3.752M |
| September 30, 2021 | -9.264M |
| June 30, 2021 | -3.731M |
| March 31, 2021 | -0.446M |
| December 31, 2020 | 2.448M |
| September 30, 2020 | -4.202M |
| June 30, 2020 | -1.845M |
| March 31, 2020 | -0.895M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-17.26M
Minimum
Mar 2023
2.448M
Maximum
Dec 2020
-6.002M
Average
-6.290M
Median
Cash from Operations (Quarterly) Benchmarks
| Stryker Corp | 1.474B |
| Perspective Therapeutics Inc | -8.902M |
| Retractable Technologies Inc | -2.703M |
| Xtant Medical Holdings Inc | -5.088M |
| Catheter Precision Inc | -1.697M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 22.43M |
| Cash from Financing (Quarterly) | 0.311M |
| Free Cash Flow | -41.50M |
| Free Cash Flow Per Share (Quarterly) | -0.2517 |
| Free Cash Flow to Equity (Quarterly) | -15.70M |
| Free Cash Flow Yield | -11.68% |